SEC Form 4 · accession 0001140361-15-031824
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George A Joulwan
Director
Period of report
Aug 13, 2015
Accepted (ET)
Aug 14, 2015 · 9:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 13, 2015 | M | 7,200 | $17.51 | A | 26,700 | D | |
| Common StockF1,F2 | Aug 13, 2015 | S | 7,200 | $34.72 | D | 19,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | $17.51 | Aug 13, 2015 | M | 7,200 | D | — | Jul 16, 2020 | Common Stock | 7,200 | 3,600 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on July 17, 2013.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.71 to $34.81, inclusive.
- F3The option vests in three equal installments in July 2014, 2015 and 2016.